1st Quarter - Termination

BUCHANAN INGERSOLL & ROONEY PC for SHIRE PHARMACEUTICALS INC

Firm
Client
Income
$10,000
Expenses
—
Terminated
Feb 1, 2012

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Life Sciences Investment Act; ESRD orphan drugs; health care reform implementation; DEA Quotas; Drug shortage; CMS issues; PDUFA; exclusivity periods

Foreign entity interest: Shire has its US headquarters in Wayne, PA. Its ultimate parent is Shire LTF, incorporated in Jersey.

LobbyistCovered position, as disclosed
MARTIN A CORRY —
MARK LENKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.